Continental Pharmacovigilance

Continental Pharmacovigilance helps to ensure compliance with local and international requirements. To operate more effectively across multiple regions and health authorities. The global liver diseases therapeutics market totaled nearly $24.5 billion in 2014 and is projected to approach $33.8 billion by 2019, registering a compound annual growth rate (CAGR) of 6.7% through 2019.

  • Pharamcovigilance USA
  • Pharamcovigilance EUROPE
  • Pharamcovigilance MIDDLE EAST
  • Pharamcovigilance ASIA PACIFIC

Related Conference of Continental Pharmacovigilance

Continental Pharmacovigilance Conference Speakers